"There have been previous reports of increased levothyroxine overuse in the US, but this is the first paper to describe the nature of the drivers of the overuse," first author Juan P Brito, MD, of the Division of Endocrinology, Diabetes, Metabolism & Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, told Medscape Medical News.